Clinical correlates of CSF Aβ42 and tau in patients with mild cognitive impairment

被引：0
|
作者：
Schoonenboom, NS
Visser, PJ
Van Elk, EJ
Lindeboom, J
Mulder, C
Scheltens, P
机构：
[1] VU Univ Med Ctr, Alzheimer Ctr, Dept Neurol, Amsterdam, Netherlands
[2] VU Univ Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
[3] VU Univ Med Ctr, Alzheimer Ctr, Dept Psychol, Amsterdam, Netherlands
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81190-4
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [21] Clinical correlates of executive dysfunctions in mild cognitive impairment
    Vicini-Chilovi, B.
    Conti, M.
    Bertoletti, E.
    Zanetti, M.
    Rozzini, L.
    Padovani, A.
    JOURNAL OF NEUROLOGY, 2009, 256 : S72 - S73
  • [22] Cognitive testing and correlation with CSF Abeta, tau and Ptau levels in subjects with Mild Cognitive Impairment
    Rotondo, E.
    Galimberti, D.
    Vimercati, R.
    Corti, P.
    Bergamaschini, L.
    Fenoglio, C.
    Serpente, M.
    Cantoni, C.
    De Riz, M.
    Bresolin, N.
    Vergani, C.
    Scarpini, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 78 - 78
  • [23] CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV
    Guha, Debjani
    Misra, Vikas
    Chettimada, Sukrutha
    Yin, Jun
    Gabuzda, Dana
    VIRUSES-BASEL, 2024, 16 (01):
  • [24] Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
    Andreasen, N
    Minthon, L
    Vanmechelen, E
    Vanderstichele, H
    Davidsson, P
    Winblad, B
    Blennow, K
    NEUROSCIENCE LETTERS, 1999, 273 (01) : 5 - 8
  • [25] Prediction of Alzheimer's disease using the CSF Aβ42/Aβ40 ratio in patients with mild cognitive impairment
    Hansson, Oskar
    Zetterberg, Henrik
    Buchhave, Peder
    Andreasson, Ulf
    Londos, Elisabet
    Minthon, Lennart
    Blennow, Kaj
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (05) : 316 - 320
  • [26] Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia
    Hosseini, Akram A.
    Brown, Thomas
    Mannino, Luca
    Gran, Bruno
    Junaid, Kehinde
    Mukaetova-Ladinska, Elizabeta B.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (02) : 771 - 780
  • [27] Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment
    Gonzales, Mitzi M.
    Insel, Philip S.
    Nelson, Craig
    Tosun, Duygu
    Schoell, Michael
    Mattsson, Niklas
    Sacuiu, Simona
    Bickford, David
    Weiner, Michael W.
    Mackin, R. Scott
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (10) : 1305 - 1311
  • [28] CSF biomarkers for mild cognitive impairment
    Blennow, K
    JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) : 224 - 234
  • [29] FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment
    Fellgiebel, Andreas
    Scheurich, Armin
    Bartenstein, Peter
    Mueller, Matthias J.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2007, 155 (02) : 167 - 171
  • [30] Cerebrospinal fluid TAU protein and amyloid β42 correlation with the neuropsychological examination in mild cognitive impairment and mild Alzheimer disease patients
    Speth, A.
    Sindic, C.
    Seron, X.
    Ivanoiu, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 183 - 183
12345